Lara Sullivan
Vorstandsvorsitzender bei PYXIS ONCOLOGY, INC.
Vermögen: 8 Mio $ am 30.04.2024
Aktive Positionen von Lara Sullivan
| Unternehmen | Position | Beginn | Ende |
|---|---|---|---|
| PYXIS ONCOLOGY, INC. | Direktor/Vorstandsmitglied | 11.12.2019 | - |
| Vorstandsvorsitzender | 11.12.2019 | - | |
| Präsident | - | - |
Karriereverlauf von Lara Sullivan
Ehemalige bekannte Positionen von Lara Sullivan
| Unternehmen | Position | Beginn | Ende |
|---|---|---|---|
SpringWorks Therapeutics LLC
 SpringWorks Therapeutics LLC BiotechnologyHealth Technology SpringWorks Therapeutics, Inc. engages in the development of biopharmaceutical products for patients with severe rare diseases and cancer. It focuses in advancing the pipeline of standalone and combination therapies with an initial focus on rare diseases and oncology. The company was founded by Lara S. Sullivan in 2017 and is headquartered in Stamford, CT. | Direktor/Vorstandsmitglied | 01.01.2017 | 01.01.2018 |
| Gründer | 01.01.2017 | 01.01.2018 | |
| Präsident | 01.01.2017 | 01.01.2018 | |
| PFIZER, INC. | Corporate Officer/Principal | 01.01.2011 | 01.01.2017 |
McKinsey & Co., Inc.
 McKinsey & Co., Inc. Miscellaneous Commercial ServicesCommercial Services McKinsey & Co., Inc. provides management consulting services. It specializes in design, marketing and sales, analytics, operations, transformation and restructuring, risk, strategy and corporate finance, and sustainability and resource productivity. The company was founded by James O. McKinsey in 1926 and is headquartered in New York, NY. | Corporate Officer/Principal | - | - |
| REXAHN PHARMACEUTICALS, INC. | Direktor/Vorstandsmitglied | 01.02.2019 | - |
Ausbildung von Lara Sullivan
| The Wharton School of the University of Pennsylvania | Masters Business Admin |
| Cornell University | Undergraduate Degree |
| Perelman School of Medicine | Graduate Degree |
Statistik
International
| Vereinigte Staaten | 9 |
Operativ
| Director/Board Member | 3 |
| President | 2 |
| Corporate Officer/Principal | 2 |
Sektoral
| Health Technology | 5 |
| Consumer Services | 4 |
| Commercial Services | 2 |
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Unternehmensverbindungen
| Börsennotierte Unternehmen | 2 |
|---|---|
| PYXIS ONCOLOGY, INC. | Health Technology |
| PFIZER, INC. | Health Technology |
| Private Unternehmen | 3 |
|---|---|
SpringWorks Therapeutics LLC
SpringWorks Therapeutics LLC BiotechnologyHealth Technology SpringWorks Therapeutics, Inc. engages in the development of biopharmaceutical products for patients with severe rare diseases and cancer. It focuses in advancing the pipeline of standalone and combination therapies with an initial focus on rare diseases and oncology. The company was founded by Lara S. Sullivan in 2017 and is headquartered in Stamford, CT. | Health Technology |
Rexahn Pharmaceuticals, Inc.
 Rexahn Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Rexahn Pharmaceuticals, Inc. is a clinical stage biopharmaceutical company, which engages in the research and development of oncology therapeutics. Its drug candidates include the following: RX-31171 for pancreatic, bladder, colon, and lung cancer; and RX-5902 for metastatic triple negative breast cancer. The company was founded by Chang Ho Ahn on March 19, 2001 and is headquartered in Rockville, MD. | Health Technology |
McKinsey & Co., Inc.
McKinsey & Co., Inc. Miscellaneous Commercial ServicesCommercial Services McKinsey & Co., Inc. provides management consulting services. It specializes in design, marketing and sales, analytics, operations, transformation and restructuring, risk, strategy and corporate finance, and sustainability and resource productivity. The company was founded by James O. McKinsey in 1926 and is headquartered in New York, NY. | Commercial Services |
- Börse
- Insiders
- Lara Sullivan
- Erfahrung
